These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
365 related items for PubMed ID: 29731507
21. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma]. Liang Y, Chen XD, Lü BJ, Zhou CY, Zhang XF, Shi HY. Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343 [Abstract] [Full Text] [Related]
22. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift. Reade CJ, McVey RM, Tone AA, Finlayson SJ, McAlpine JN, Fung-Kee-Fung M, Ferguson SE. J Obstet Gynaecol Can; 2014 Feb; 36(2):133-140. PubMed ID: 24518912 [Abstract] [Full Text] [Related]
24. Management of advanced-stage primary carcinoma of the fallopian tube: case report and literature review. Kuscu E, Oktem M, Haberal A, Erkanli S, Bilezikci B, Demirhan B. Eur J Gynaecol Oncol; 2003 Feb; 24(6):557-60. PubMed ID: 14658603 [Abstract] [Full Text] [Related]
27. Serous tubal intraepithelial carcinoma localizes to the tubal-peritoneal junction: a pivotal clue to the site of origin of extrauterine high-grade serous carcinoma (ovarian cancer). Seidman JD. Int J Gynecol Pathol; 2015 Mar; 34(2):112-20. PubMed ID: 25675178 [Abstract] [Full Text] [Related]
37. Concurrent primary peritoneal low-grade serous carcinoma and endometrial high-grade serous carcinoma. Lockyer MG, Deavers MT, Zarrin-Khameh N. Int J Gynecol Pathol; 2015 May 20; 34(3):288-92. PubMed ID: 25760900 [Abstract] [Full Text] [Related]
38. Disease Distribution in Low-stage Tubo-ovarian High-grade Serous Carcinoma (HGSC): Implications for Assigning Primary Site and FIGO Stage. Singh N, Benson JL, Gan C, Anglesio M, Arora R, Faruqi AZ, Hirschowitz L, Kommoss F, Scott K, Trevisan G, Leen SLS, Wilkinson N, Gilks CB, McCluggage WG. Int J Gynecol Pathol; 2018 Jul 20; 37(4):324-330. PubMed ID: 28787323 [Abstract] [Full Text] [Related]
39. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary. Leonhardt K, Einenkel J, Sohr S, Engeland K, Horn LC. Int J Gynecol Pathol; 2011 Sep 20; 30(5):417-24. PubMed ID: 21804388 [Abstract] [Full Text] [Related]